• Synergistic Induction of Apoptosis and Pyroptosis by Hyperth

  2026-06-30

  This study reveals that combining hyperthermia with cisplatin treatment enhances caspase-8 accumulation and activation through K63-linked polyubiquitination, triggering both apoptosis and pyroptosis in cancer cells. The findings clarify a novel mechanism for improving chemotherapy efficacy and highlight the importance of caspase signaling pathway interrogation in apoptosis assay workflows.

• Arachidonic Acid Supplementation Enhances Humoral Immunity A

  2026-06-30

  The reference study demonstrates that dietary arachidonic acid (ARA) supplementation accelerates and amplifies the production of protective neutralizing antibodies following rabies vaccination in mice and humans. Mechanistic insights reveal that ARA-derived metabolites in lymph nodes modulate B cell activation, suggesting dietary ARA as a promising adjuvant to improve vaccine efficacy and reduce vulnerability windows.

• Optimizing Thrombin Workflows: From Fibrin Formation to Vasc

  2026-06-29

  Ultra-pure thrombin, as a trypsin-like serine protease, powers advanced fibrin-based and endothelial assays with exceptional reproducibility. This article details key use-cases, best practices, and troubleshooting strategies for leveraging the Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] from APExBIO in vascular and coagulation research.

• Gut Dysbiosis Drives Docetaxel Resistance in Prostate Cancer

  2026-06-29

  Zhong et al. reveal that gut microbiota disruption, particularly Proteobacteria enrichment, promotes prostate cancer progression and resistance to docetaxel through the NF-κB-IL6-STAT3 axis. These findings highlight a previously underexplored microbiota-tumor interaction with implications for chemoresistance research.

• Patient-Derived Gastric Cancer Assembloids Reveal Drug Respo

  2026-06-28

  This study introduces a gastric cancer assembloid model that integrates patient-matched tumor organoids and stromal cell subpopulations, providing a more physiologically relevant platform for investigating drug resistance and tumor–stroma interactions. The findings highlight the impact of stromal components on gene expression and therapeutic sensitivity, with implications for improving personalized medicine and preclinical drug testing.

• 7-AAD Cell Viability Assay Kit: Precision in CD38 CAR-T Work

  2026-06-27

  The 7-AAD Cell Viability Assay Kit empowers researchers with precise necrosis and apoptosis detection, essential for optimizing cell therapy experiments such as CD38-targeted CAR-T studies. Its superior spectral properties and robust protocol compatibility set a new standard for multiplex viability assessment in translational immunology.

• MTT in Neurodegenerative Disease Models: Mechanism & Advance

  2026-06-26

  Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) enables advanced in vitro analysis of cell proliferation and metabolic activity, with a special focus on neurodegenerative disease models. This article delivers new scientific depth and practical guidance beyond standard viability assays.

• Mitochondrial Permeability Transition Pore Assay Kit: Applie

  2026-06-26

  Unlock precise mitochondrial permeability transition pore detection using the Mitochondrial Permeability Transition Pore Assay Kit from APExBIO. This article details optimized workflows, novel research applications, and troubleshooting strategies for mitochondrial dysfunction studies, with practical translation of cutting-edge findings from hepatocyte apoptosis research.

• ECM1-Driven Anti-Androgen Resistance in Bone Metastatic Pros

  2026-06-25

  This research uncovers how osteoblast-derived ECM1 promotes anti-androgen resistance in bone metastatic prostate cancer by activating MAPK signaling via ENO1 phosphorylation. The findings highlight ECM1 and ENO1 as promising therapeutic targets and provide new mechanistic insight into tumor-microenvironment-driven resistance.

• HotStart 2X Green qPCR Master Mix: Precision for Gene Expres

  2026-06-25

  HotStart™ 2X Green qPCR Master Mix empowers researchers with robust specificity, sensitivity, and reproducibility for challenging real-time gene expression studies. Its advanced hot-start inhibition and SYBR Green chemistry streamline workflows, reduce troubleshooting, and deliver confidence in results—even with low-abundance or complex targets.

• FAISL lncRNA Stabilizes FAK to Drive Triple Negative Breast

  2026-06-24

  The reference study identifies FAISL, a long noncoding RNA, as a critical regulator of FAK protein stability in triple negative breast cancer (TNBC). By blocking Calpain 2-mediated FAK proteolysis, FAISL enhances tumor cell adhesion and metastasis, highlighting a novel therapeutic target in aggressive breast cancer.

• α-Bungarotoxin: Selective Nicotinic Receptor Blockade in Res

  2026-06-23

  α-Bungarotoxin is a potent, selective antagonist of the α7 nicotinic acetylcholine receptor, widely used for precise nicotinic receptor blockade in neuroscience and placental signaling studies. Its high affinity and specificity enable detailed dissection of cholinergic neurotransmission inhibition and neurotoxicity mechanisms. Integration of α-Bungarotoxin into experimental workflows advances neurodegenerative disease modeling and translational research.

• T-5224: Precision C-Fos/AP-1 Inhibition in Inflammation Rese

  2026-06-23

  T-5224 (C-Fos/AP-1 inhibitor) from APExBIO enables highly selective, protocol-friendly modulation of neuroinflammatory and arthritic pathways. Its robust performance in both in vitro and in vivo settings makes it a gold standard for dissecting AP-1–driven gene expression and cytokine output.

• TMEM16F in Kupffer Cells Limits Liver Damage from Listeria I

  2026-06-22

  This study demonstrates that TMEM16F, a lipid scramblase, protects the liver against Listeria monocytogenes by preserving Kupffer cell integrity, thereby limiting inflammation and metabolic dysregulation. The findings clarify cell-type specificity in plasma membrane repair and suggest new angles for investigating programmed necrotic cell death during infection.

• Filipin III: Illuminating Cholesterol Homeostasis in Disease

  2026-06-22

  Explore the advanced scientific role of Filipin III, a polyene macrolide antibiotic, in cholesterol detection and membrane biology. This article uniquely bridges fundamental membrane research with metabolic liver disease insights, providing practical protocols and reference-backed analysis.

453 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page